FIELD: chemistry.
SUBSTANCE: invention concerns compounds of the formula M-N-O-P-G, where M is a metal-chelating agent (in a complex with a radioactive metal nuclide or not), N-O-P is a linker, and G is a peptide for target transportation to a GRP receptor. Also the invention concerns methods of visualisation for a patient with the help of the claimed compounds, methods of obtaining a diagnostic visualisation and radiotherapeutic medium.
EFFECT: improved compounds for application in diagnostics visualisation or therapy.
49 cl, 51 dwg, 8 tbl, 58 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BLOOD DEPOT AGENTS FOR MAKING NUCLEAR MAGNETIC RESONANCE DIAGNOSIS | 1999 |
|
RU2250765C2 |
| METHOD OF PRODUCING GAMMA AMIDES OF GLUTAMIC ACID | 1999 |
|
RU2395490C2 |
| PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
| FGF21 DERIVATIVES AND USE THEREOF | 2015 |
|
RU2729011C2 |
| METHOD OF OBTAINING PEPTIDES | 0 |
|
SU639446A3 |
| MASP INHIBITING COMPOUNDS AND APPLICATIONS THEREOF | 2020 |
|
RU2840441C2 |
| ANALOGUES OF EGF(A) WITH SUBSTITUENTS-FATTY ACIDS | 2017 |
|
RU2747877C2 |
| METHOD FOR PRODUCING BOC-THZ-PHE-D-TRP-LYS(BOC)-THR-NHCHCHNH-DOTA CONJUGATE BEING A PRECURSOR FOR ANTI-TUMOR RADIOPHARMACEUTICS | 2022 |
|
RU2795447C1 |
| METHOD OF PREPARING TETRADECAPEPTIDE | 0 |
|
SU904519A3 |
| CONJUGATE INCLUDING LIGAND, SPACER, PEPTIDE LINKER AND BIOMOLECULE | 2020 |
|
RU2807081C2 |
